Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Weight Management After Cancer for Survivors in Rural Communities

NCT07426952 · View on ClinicalTrials.gov ↗

Study Summary

This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment. The study will answer two main questions: * Can we successfully recruit and keep participants in the study, and will they find the program helpful and easy to follow? * Will people who join the program see better results in areas like weight, symptoms, diet, physical activity, and confidence in managing their health compared to those who receive standard care? Here's what participants will do: * Visit their clinic twice (about 12 weeks apart) to be weighed, have their blood pressure checked, give a blood sample, and complete a short walking test * Fill out online surveys about their health, diet, physical activity, symptoms, and confidence in managing their health * Be randomly assigned (like flipping a coin) to either receive the WeCan-Rural program or standard health information * If assigned to the program, attend 12 weekly one-hour video sessions on Zoom with a trained therapist

Interventions

  • BEHAVIORAL WeCan-Rural Program

Study Locations (3)

North Carolina

  • Maria Parham Cancer Center — Henderson
  • Scotland Health — Laurinburg
  • UNC Health Southeastern — Lumberton

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-01-13
Est. Completion 2026-12-31
Phase NA

Sponsor

Duke University

1,129 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07426952

The ClinicalTrials.gov registry entry for NCT07426952 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,129 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention — of which WeCan-Rural Program is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07426952 reports 3 study locations spanning 1 distinct geographic area — top geographies include North Carolina. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07426952 about?

NCT07426952 is a clinical study titled "Weight Management After Cancer for Survivors in Rural Communities". This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment. The study will answer...

What is the current status of trial NCT07426952?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01-13. Estimated completion is 2026-12-31.

What conditions does trial NCT07426952 study?

This clinical trial studies the following conditions: Breast Cancer, Weight Management, Cardiovascular (CV) Risk, Breast Cancer Survivorship. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07426952?

The interventions under investigation include: WeCan-Rural Program (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07426952?

This trial is sponsored by Duke University, which has 1,129 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07426952 being conducted?

This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial